Cogent Biosciences
COGT
#2766
Rank
NZ$10.25 B
Marketcap
NZ$63.20
Share price
-4.24%
Change (1 day)
406.81%
Change (1 year)

Market capitalization of Cogent Biosciences (COGT)

Market cap: NZ$10.25 Billion

As of March 2026 Cogent Biosciences has a market cap of NZ$10.25 Billion. This makes Cogent Biosciences the world's 2766th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cogent Biosciences from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$10.25 B-0.46%
2025NZ$10.30 B579.77%
2024NZ$1.51 B89.32%
2023NZ$0.80 B-37.08%
2022NZ$1.27 B154.22%
2021NZ$0.50 B3.08%
2020NZ$0.48 B1381.02%
2019NZ$32.79 M-83.33%
2018NZ$0.19 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Cogent Biosciences was reported to be:

NZ$10.25 Billion
by Nasdaq info icon info icon
NZ$10.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
NZ$1.60 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$35.47 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA